Luskin MR, Leonard JT. Blinatumomab and better BCR::ABL1 inhibition begets better bone marrow transplant outcomes. haematol [Internet]. 2025Nov.1 [cited 2025Dec.5];110(11):2560-1. Available from: https://haematologica.org/article/view/12112